BioSpace News Archive

Gritstone bio, Inc., a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, reported financial results for the first quarter ended March 31, 2021 and reviewed business highlights.

Abbott (NYSE: ABT) today announced a new trial focused on improving the treatment for people simultaneously battling both atrial fibrillation (AFib) and heart failure

Waterlase pediatric dentists are invited to join a community dedicated to integrated training and mentorship to deliver a gentler treatment to dentistry’s smallest patients

New company highlights patients, holistic approach to providing access to medicine, and path to further progress

Pfizer Canada, Novatek International, Cognistat and Member of Parliament for Saint-Laurent, Emmanuella Lambropoulos, have joined forces to achieve Hope for Dementia’s mission to end isolation and loneliness in senior care homes.

Ambina Partners LLC, a private investment firm supporting growth-oriented middle market businesses, sold PeriGen Inc., a leading provider of perinatal healthcare software solutions to Halma plc.

This is the Company’s third issued patent in its chronic neurodegenerative patent family.

However, in parallel, the Company will undertake efforts to confirm and expand on Cepharanthine’s noted benefit in previously examined cancers, while also assessing potential benefit across a panel of untested cancer types.

Canada’s universal, publicly funded health care system is a source of pride for Canadians. The Government of Canada is working closely with provincial and territorial governments to strengthen health care and adapt the system to the challenges of delivering health care during the COVID-19 pandemic, and as we move into recovery.

CHOP-led study found depressive symptoms were uniquely associated with pandemic-related income loss and financial strain in two different countries, independent of anxiety